title: Follicular and late luteal phase serum fluoxetine levels in women suffering from late luteal phase dysphoric disorder.
authors.affiliation: Women's Health Concerns Clinic, St. Joseph's Hospital, Hamilton, Ontario, Canada.
authors.forename: D E
authors.initials: DE
authors.lastname: Stewart
authors.forename: M
authors.initials: M
authors.lastname: Fairman
authors.forename: S
authors.initials: S
authors.lastname: Barbadoro
authors.forename: P
authors.initials: P
authors.lastname: Zownir
authors.forename: M
authors.initials: M
authors.lastname: Steiner
mesh_terms: D000328:Adult; D004311:Double-Blind Method; D005260:Female; D005473:Fluoxetine / Q000031:analogs & derivatives / Q000493:pharmacokinetics* / Q000627:therapeutic use; D005498:Follicular Phase / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D008183:Luteal Phase / Q000187:drug effects / Q000502:physiology*; D008875:Middle Aged; D011293:Premenstrual Syndrome / Q000097:blood* / Q000188:drug therapy / Q000523:psychology; D011446:Prospective Studies
chemical_list: D005473:Fluoxetine; C036139:norfluoxetine